To ensure that expenses relating to the acquisition or use of devices for use in the detection of fentanyl, xylazine, and other emerging adulterant substances, including test strips, are allowable expenses under certain grant programs.
This bill allows federal grant programs to pay for fentanyl and xylazine test strips and similar detection devices that help people identify dangerous substances mixed into drugs before use. The legislation modifies two existing federal programs—the 21st Century Cures Act grant program and the Public Health Service Act grants administered by the Substance Abuse and Mental Health Services Administration—to explicitly authorize spending on these detection devices. The bill is intended to help reduce overdose deaths by making test strips more accessible through federally funded harm reduction and substance abuse treatment programs. No specific funding amount or timeline is included in the legislation; it simply clarifies that existing grant money can be used for this purpose. The bill was introduced in September 2023 and affects any organization receiving federal grants for substance abuse prevention or treatment services.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.